Abstract P2-12-01: Patient attitudes, experience and results of screening for minimal residual disease (MRD) for therapeutic intervention von Nivar, Isoris, Kauffman, Tara, Bayne, Lauren, Wiley, Paul, Goodspeed, Brooke, Feldman, Michael, Chodosh, Lewis, Clark, Amy, DeMichele, Angela

Volltext

Abstract LB138: The conception of an Oncology Neurodiversity Work Group to address cancer disparity for individuals with autism and intellectual or developmental disability (IDD) a... von Bhatia, Avnish K., Fossi, Alexander, Goodspeed, Brooke L., Tobias, Jane, McNair, Christopher, McBee, Dwight, Ross, Wendy

Volltext

Abstract PD9-11: Identifying breast cancer survivors with dormant disseminated tumor cells: The PENN-SURMOUNT screening study von Bayne, Lauren, Nivar, Isoris, Goodspeed, Brooke, Deluca, Shannon, Wileyto, E. Paul, Shih, Natalie, Nayak, Anupma, Feldman, Michael D, Edwards, Joshua, Fox, Kevin, Matro, Jennifer M., Domchek, Susan, Knollman, Hayley, Jankowitz, Rachel, Bradbury, Angela, Shah, Payal D., Graves, Jewell, Woodfield, George, Chislock, Elizabeth, Wang, Jianping, Belka, George, Chodosh, Lewis A., Clark, Amy S., DeMichele, Angela

Volltext

Abstract P5-08-01: Pilot study of a patient-reported outcome (PRO) measurement strategy to determine impact of screening for minimal residual disease (MRD) in high-risk breast canc... von Kaufmann, Tara, Chang, Patrick, Rosenberg, Shoshana, Frank, Elizabeth, Hobbs, Brian, Bayne, Lauren J., Nivar, Isoris, Goodspeed, Brooke L., Rohn, Killian M., Kugler, Emily M., Fox, Kevin, Domchek, Susan, Bradbury, Angela, Shah, Payal, Knollman, Hayley, Jankowitz, Rachel C., Makhlin, Igor, Clark, Amy S., Chodosh, Lewis A., DeMichele, Angela, Goodfellow, Katherine

Volltext